Chief Executive Officer TJ Johnson to assume role of Executive Chairman at the end of first quarter 2019 John Lubniewski , President and Chief Operating Officer, appointed as successor TUCSON, Ariz. , Jan. 14, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc….
TUCSON, Jan. 07, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced preliminary, unaudited financial results for the full year ended December 31, 2018 ….
TUCSON, Ariz. , Dec. 18, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the formation of a French subsidiary, HTG Molecular Diagnostics France SARL (“HTG France”) in November 2018…
GÖTEBORG, Sweden and TUSCON, Ariz., Dec. 05, 2018 (GLOBE NEWSWIRE) – TATAA Biocenter, Europe’s leading provider of genomic services, and HTG Molecular Diagnostics, Inc (HTG) (Nasdaq: HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the…
HTG and Firalis are nominated for Best Innovative Trial Design Leading to Quicker and Better Therapeutic Outcome by the Galien Foundation Medstartup 2018.
TUCSON, Ariz. , Nov. 12, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the Canaccord…
Revenue increased 26% and 101% for the three and nine months ended September 30, 2018 compared to the respective prior year periods Call scheduled for today, November 8 , at 4:30 pm ET TUCSON, Ariz. , Nov. 08, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc….
TUCSON, Ariz. , Oct. 31, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the appointment of Maureen T. Cronin , Ph.D., as the Company’s Chief Scientific Officer…
TUCSON, Ariz. , Oct. 25, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that it will report its financial results for the three and nine months ended September 30, 2018…
HTG’s extraction-free, targeted next-generation sequencing technology adopted to support the IOR’s research and clinical trials in hematological cancers and solid tumors TUCSON, Ariz. , Oct. 23, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (“HTG”), a provider of…
Join HTG at the 2018 Society for Immunotherapy of Cancer (SITC) and learn about our new HTG EdgeSeq Precision Immuno-Oncology Panel that has 1,392 genes focused on tumor / immune interaction.
Join us at the 2018 European Society for Medical Oncology Congress October 19 - 23 to learn how our NGS-based HTG EdgeSeq chemistry and automation can help shape the future of oncology.
Page last updated March 20, 2023